Daily News logo Newsletter logo   Search News    


Anti-Drug Group Applauds FDA Announcement Denying The Medicalization Of Smoked Marijuana

  Share This Story
ALBANY, N.Y. (EWORLDWIRE) Apr 22, 2006

DAMMADD (DADS AND MAD MOMS AGAINST DRUG DEALERS) and other parent groups from all over the country have been petitioning the FDA to make a ruling on the medicalization of marijuana. After years of letter writing, the FDA agreed with arguments against legalization and with the 1999 report by the Institute of Medicine of the National Academy of Science. In the report, there were six recommendations made, with recommendation number 5:

"If there is any future for marijuana as a medicine, it lies in its isolated components, the cannabinoids and their synthetic derivatives. Isolated cannabinoids will provide more reliable effects than crude plant mixtures. Therefore, the purpose of clinical trials of smoked marijuana would not be to develop marijuana as a licensed drug, but such trials could be a first step towards the development of rapid-onset, nonsmoked cannabinoid delivery systems."

Pro drug organizations such as the Drug Policy Alliance and the Marijuana Policy Project (MPP) have worked to spin the truth to deceive the American public and ignore the new and upcoming cannabis medicine Sativex that has received phase III trial approvals from the FDA. In a statement issued April 21 on http://www.commondreams.org/news2006/0421-06.htm, MPP Director of Government Relations Aaron Houston alleges the position adopted by the FDA is political, that it reflects "the decline of the FDA as an independent scientific agency," rather than a non-partisian decision-making authority.

DAMMADD Founder Steven Steiner said, "The bottom line is these organizations are using the medicalization issue as a stepping stone for full legalization of marijuana."

Steiner is calling on all Americans to join the fight against all organizations which, by virtue of this stance, work to erode and destroy family values and use sick people to further their agendas.

Further information is available in videos at Americans For Drug Free Youth Web site, www.afdfy.org, at the Otto Moulton memorial library.

For more information visit www.dammadd.org or at www.afdfy.org, call toll free 866-DAMMADD, or write to P.O. Box 95, Tioga Center, New York 13845.
HTML: http://newsroom.eworldwire.com/wr/042206/14322.htm
PDF: http://newsroom.eworldwire.com/pdf/042206/14322.pdf
ONLINE NEWSROOM: http://newsroom.eworldwire.com/2441.htm
RSS NEWSROOM: http://newsroom.eworldwire.com/xml/newsrooms/2441.xml

     
   President
   DAMMADD
   Tioga Center,    NY,    13845
   USA
   607-687-4151 (phone)
   607-687-4240 (fax)
   stevensteiner@dammadd.org
   www.dammadd.org
  



 
Support Wikipedia

NeswBlaze top writers

Find more stories recommended by Stumbleupon.

newsletter logo

What's Hot?
1 .Supermodel Bar Refaeli Adorns the Cover of the 2009 Sports Illustrated Swimsuit Issue on Newsstands Today! - 48
2 .Waterless 'Air Cooler PLUS' Beats Summer's Heat Without Making Your Home Muggy - 17
3 .Who is the sadistic killer of Paula Sladewski? - 9
4 .What Does a Traveling Carnival Have to Do with Mickey Shunick Disappearing? - 11
5 .Forevermore The 'Manson Murders' Will Flourish, Fascinate, And Feed The Media! - 7
6 .Photos: Valkyrie MEDEVAC - 9
7 .The Cult of Katniss - 9
8 .Very Young Girls Movie Review: Sex, Class and Ho Daddies - 6
9 .You Can Turn Back Time - 6
10 .These 10 Comfortable Walking Shoes Are a Step in the Right Direction - 6
Updated: 5:45 PDT     823

NewsBlaze Editors

editors

NewsBlaze Writers

news writer images

Writers Wanted

Help NewsBlaze provide daily news, including top stories, Home and Garden, Technology, The Environment and more. NewsBlaze Writer

Follow NewsBlaze

NewsBlaze Social Media Logos NewsBlaze Facebook NewsBlaze LinkedIn NewsBlaze Twitter NewsBlaze YouTube NewsBlaze MySpace NewsBlaze Fan Page NewsBlaze StumbleUpon NewsBlaze Political Cartoons NewsBlaze Editorial Cartoons
NewsBlaze 
Copyright © 2004-2012 NewsBlaze LLC
Use of this website is subject to our Terms of Service and Privacy Policy  | DMCA Notice |         Press Room